Menthacarin attenuates experimental colitis

Area of Science:

• Gastroenterology
• Pharmacology
• Immunology

Background:

• Peppermint oil and caraway oil are recognized for their spasmolytic and analgesic properties in gastrointestinal medicine.
• These natural remedies have a history of use in managing digestive discomfort.

Purpose of the Study:

• To evaluate the anti-inflammatory effects of Menthacarin, a combination of peppermint and caraway oils.
• To assess Menthacarin's efficacy in a dextran sodium sulfate (DSS)-induced murine model of colitis.

Main Methods:

• C57BL/6 mice were administered varying doses of Menthacarin (10-120 µg/g BW) or a control (0.2% agar).
• DSS-induced colitis was maintained for 8 days, with monitoring of body weight and colonoscopy.
• Colonic tissues were analyzed histologically, and key cytokines (TNFα, IL-6, IL-10, IL-1β, TGF-β) were quantified via ELISA.

Main Results:

• Menthacarin treatment led to improved macroscopic and microscopic colitis parameters compared to controls.
• Mice receiving Menthacarin exhibited reduced body weight loss during the experimental period.
• The colonic cytokine profile shifted towards a regulatory and anti-inflammatory phenotype in Menthacarin-treated mice.

Conclusions:

• Menthacarin effectively attenuates experimental colitis in a murine model.
• The findings suggest Menthacarin holds promise as a complementary therapy for inflammatory bowel disease (IBD).